Ocular Therap

Forecast & Rating11 analysts currently cover Ocular Therap, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $27.09, about 218.5% upside from the current price of $8.51. Price targets range from $18.00 to $34.00 — a wide spread, showing clear disagreement over just how much Ocular Therap can rise. Historically, about 12.6% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Ocular Therap closely still see room for the stock to rise. Data as of Jul 24, 2026; for reference only and not investment advice.